Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Base Excision Repair
100%
Histopathology
100%
Adenocarcinoma
30%
Overall Survival
20%
Biological Marker
10%
Hazard Ratio
10%
Patient Population
10%
Cisplatin
10%
Nursing and Health Professions
Non Small Cell Lung Cancer
100%
Adenocarcinoma
75%
Overall Survival
50%
Biological Marker
25%
Cisplatin
25%
Hazard Ratio
25%
Predictive Value
25%
Patient Population
25%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Adenocarcinoma
75%
Chemotherapy
75%
Overall Survival
50%
Cisplatin
25%
Biological Marker
25%
Keyphrases
Non-small Cell Lung Cancer Patients
100%
Doublet Therapy
10%
Triplet Chemotherapy
10%
Cisplatin Sensitivity
10%
Bioptics
10%
Biochemistry, Genetics and Molecular Biology
Base Excision Repair
100%
Overall Survival
20%
Cisplatin
10%